Answer
Genticin (gentamicin sulfate) injection crosses the placenta and risks fetal auditory or vestibular nerve damage; pregnancy safety is unestablished, animal studies showed teratogenic effects, and use is reserved for cases where maternal illness justifies the risk and the physician considers it essential, with serum monitoring required.
Sources for this answer
- Genticin (Gentamicin) 40mg/ml InjectableADVANZ Pharma · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked